Literature DB >> 29321416

Simultaneous Nontraumatic Spinal and Intracranial Subdural Hematoma.

Yuko Wada1, Takaya Kitano1, Junichi Uemura1, Yoshiki Yagita1.   

Abstract

Entities:  

Keywords:  anticoagulant; intracranial subdural hematoma; magnetic resonance imaging; spinal subdural hematoma

Year:  2018        PMID: 29321416      PMCID: PMC5995716          DOI: 10.2169/internalmedicine.0197-17

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


× No keyword cloud information.
Nontraumatic subdural hematoma (SDH) of the spine following intracranial SDH is extremely rare (1). The patient was 67-year-old woman receiving anticoagulant therapy following mitral valve replacement who developed sudden onset headache. She had no history of evident trauma. Her international normalized ratio of prothrombin time (PT-INR) was 3.10. Fluid-attenuated inversion recovery (FLAIR) magnetic resonance imaging (MRI) of the brain showed a thin SDH (Picture A). She was treated conservatively and the target PT-INR range was 2.0-2.5. On the 11th day of hospitalization, Brain MRI revealed that the SDH had increased in size (Picture B). She also complained of radiating pain in her left leg. Both T1-weighted and T2-weighted images of the spine showed areas of high signal intensity extending from the C7 level to the S2 level in the spinal subdural space (arrows in Picture C and D). Axial MRI at the L5 level showed an inverted Mercedes Benz sign (arrows in Picture E) (2).
Picture.
The authors state that they have no Conflict of Interest (COI).
  2 in total

1.  Simultaneous cranial and spinal subdural hematoma.

Authors:  Satoshi Yamaguchi; Kaoru Kurisu; Kazunori Arita; Masaaki Takeda; Itaru Tani; Osamu Araki
Journal:  Neurol Med Chir (Tokyo)       Date:  2005-12       Impact factor: 1.742

2.  Inverted Mercedes Benz sign in lumbar spinal subdural hematoma.

Authors:  Manish K Kasliwal; Larry R Shannon; John E O'Toole; Richard W Byrne
Journal:  J Emerg Med       Date:  2014-10-01       Impact factor: 1.484

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.